Cargando…

Ferroptosis: a new approach for immunotherapy

Detalles Bibliográficos
Autores principales:	Zeng, Chong, Tang, Hongfeng, Chen, Hanwen, Li, Mojuan, Xiong, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665172/ https://www.ncbi.nlm.nih.gov/pubmed/33298853 http://dx.doi.org/10.1038/s41420-020-00355-2

Ejemplares similares

Construction and validation of a risk scoring model for diffuse large B-cell lymphoma based on ferroptosis-related genes and its association with immune infiltration
por: Xiong, Dan, et al.
Publicado: (2021)

Ferroptosis hijacking by Mycobacterium tuberculosis
por: Gan, Boyi
Publicado: (2023)

Bioengineering of bacteria for cancer immunotherapy
por: Nguyen, Dinh-Huy, et al.
Publicado: (2023)

Ferroptosis, necroptosis, pyroptosis, and cuproptosis in cancer: a comparative bibliometric analysis
por: Wu, Haiyang, et al.
Publicado: (2023)

Multifaceted mechanisms mediating cystine starvation-induced ferroptosis
por: Shi, Zhennan, et al.
Publicado: (2021)

Heterogeneous PD-L1 expression in metastases impacts immunotherapy response
por: Hu, Xiaoqian, et al.
Publicado: (2023)

Ferroptosis in cancer and cancer immunotherapy
por: Zhao, Lei, et al.
Publicado: (2022)

Two contrasting papers stimulate a commentary on the origins of tumour immunology, current cancer immunotherapies, and the future potential for cancer immunotherapy
por: Bodmer, Walter
Publicado: (2022)

Cancer immunotherapy comes of age and looks for maturity
por: Finck, Amanda, et al.
Publicado: (2020)

Immunotherapy in COVID-19: why, who, and when?
por: Sinha, Pratik, et al.
Publicado: (2021)

Immunotherapies for COVID-19: lessons learned from sepsis
por: Remy, Kenneth E, et al.
Publicado: (2020)

Acquired mechanisms of immune escape in cancer following immunotherapy
por: Bryan Iorgulescu, J., et al.
Publicado: (2018)

From macrophage biology to macrophage-based cellular immunotherapies
por: Mass, Elvira, et al.
Publicado: (2021)

Immune-related adverse events and the balancing act of immunotherapy
por: Conroy, Michael, et al.
Publicado: (2022)

Potential solutions for manufacture of CAR T cells in cancer immunotherapy
por: Blache, Ulrich, et al.
Publicado: (2022)

Towards evidence-based response criteria for cancer immunotherapy
por: Garralda, Elena, et al.
Publicado: (2023)

T-cell tumour exclusion and immunotherapy resistance: a role for CAF targeting
por: Hanley, Christopher J., et al.
Publicado: (2020)

An NADPH sensor that regulates cell ferroptosis
por: Kuang, Guixing, et al.
Publicado: (2022)

COVID-19 vaccination and cancer immunotherapy: should they stick together?
por: Brest, Patrick, et al.
Publicado: (2021)

Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era
por: Abid, Muhammad Bilal
Publicado: (2022)

T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all
por: Gaudeaux, P., et al.
Publicado: (2022)

Zoonotic malaria requires new policy approaches to malaria elimination
por: Fornace, Kimberly M., et al.
Publicado: (2023)

Protein subcellular localization and functional studies in horticultural research: problems, solutions, and new approaches
por: Guo, Ye, et al.
Publicado: (2022)

T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy
por: Garaud, Soizic, et al.
Publicado: (2022)

Precision intervention of cell type-specific targeting is required for future cancer immunotherapy
por: Cai, Yitong, et al.
Publicado: (2023)

Real world evidence of long-term benefits from allergen-specific immunotherapy (AIT)
por: Scadding, Guy
Publicado: (2021)

Rho-ROCK signaling mediates entotic cell death in tumor
por: Zeng, Chong, et al.
Publicado: (2020)

An ionizable lipid toolbox for RNA delivery
por: Han, Xuexiang, et al.
Publicado: (2021)

Reply to the commentary “Liquid gold: do we need to fraction fresh colostrum for oral immunotherapy in premature infants?”
por: Kazemian, Sina, et al.
Publicado: (2022)

Role of ferroptosis in esophageal cancer and corresponding immunotherapy
por: Fan, Xin, et al.
Publicado: (2023)

The grace of aging with ART: Ex vivo dendritic cell-based immunotherapy restores HIV-specific functional CD8(+) T-cells
por: Mehraj, Vikram, et al.
Publicado: (2022)

Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours
por: Oosting, Sjoukje F, et al.
Publicado: (2022)

Initiation of a new infection control system for the COVID-19 outbreak
por: Chen, Xuejiao, et al.
Publicado: (2020)

Strategies for cancer-care resilience during the new COVID-19 wave in China
por: Tang, Liang V, et al.
Publicado: (2023)

Role of ferroptosis on tumor progression and immunotherapy
por: Gong, Deting, et al.
Publicado: (2022)

Comment on Surendran et al. The Missed Opportunity of Patient-Centered Medical Homes to Thrive in an Asian Context. Int. J. Environ. Res. Public Health 2021, 18, 1817
por: Ngoh, Sharon, et al.
Publicado: (2022)

Mpox: a new name for a new disease?
por: Beaumont, Anne-Lise, et al.
Publicado: (2023)

New function of gossypol, a natural product of cotton
por: Huang, Jinquan, et al.
Publicado: (2022)

Exploring BCG vaccination as a novel approach to prevent recurrent herpes labialis
por: Gong, Wenping, et al.
Publicado: (2023)

A multistakeholder approach to innovations in NAFLD care
por: Schattenberg, Jörn M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4v64u9skasts1ridnbciep31g7